MICS and TSV Combined

Article

Doube optimization for improved solutions

There are several reasons in support of combining anterior and posterior segment surgery. For instance, eyes presenting for cataract surgery may also have vitreoretinal problems, from vitreous degeneration to epiretinal membrane and macular hole, from diabetic retinopathy to retinal vein occlusion requiring laser treatment, and up to retinal detachment.

Recent research found epiretinal membrane in 7% of eyes presenting for cataract surgery.1 However, eyes with retinal problems can also develop cataract, both during surgery in the case of lens touch, or after surgery especially in the case of posterior tamponade by silicone oil.

The removal of a cataract in the absence of vitreous faces zonular weakness, anterior chamber instability, zonula relaxation, and the possible development of plaques especially on the posterior capsulae. In contrast, simultaneous cataract removal and posterior vitrectomy allows the surgeon to complete the vitrectomy with full shaving of the vitreous base, and to obtain better posterior tamponade with less chance of PVR recurrence. In addition, both the patient and the surgeon benefit from the single procedure for cost reason, and for the single infection risk.

MICS just before posterior surgery

The modern approach to combined anterior and posterior segment surgery includes microincision cataract surgery (MICS) and transconjunctival sutureless vitrectomy (TSV). New machines are being developed, specifically designed to optimize both types of surgery.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.